Medical Disability Examination Improvement Act of 2025

Senate Bill

S. 2493

119th Congress

Medical Disability Examination Improvement Act of 2025

In Committee

Introduced:Jul 29, 2025

Primary Sponsor

Mark Warner

D - VA

Cosponsors

3

Quick Stats

Policy Area

Health

Summary

This bill requires the Medicare Payment Advisory Commission to report on the agreements between pharmacy benefit managers (PBMs) and prescription drug plans under Medicare. The goal is to provide more transparency on how these agreements impact out-of-pocket costs for Medicare enrollees and the reimbursements received by pharmacies.

Latest Action

Read twice and referred to the Committee on Finance.

Introduced7/29/2025

StatusRead twice and referred to the Committee on Veterans' Affairs.

ChamberSenate

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Medical Disability Examination Improvement Act of 2025

This bill requires the Medicare Payment Advisory Commission to report on the agreements between pharmacy benefit managers (PBMs) and prescription drug plans under Medicare. The goal is to provide more transparency on how these agreements impact out-of-pocket c

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill requires the Medicare Payment Advisory Commission to report on the agreements between pharmacy benefit managers (PBMs) and prescription drug plans under Medicare. The goal is to provide more transparency on how these agreements impact out-of-pocket costs for Medicare enrollees and the reimbursements received by pharmacies.

Bill Number: 2493
Introduced: 7/29/2025
Status: Read twice and referred to the Committee on Veterans' Affairs.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Medical Disability Examination Improvement Act of 2025
Bill Number: 2493
Sponsor: No sponsor
Status: Read twice and referred to the Committee on Veterans' Affairs.
Introduced: 7/29/2025
Summary: This bill requires the Medicare Payment Advisory Commission to report on the agreements between pharmacy benefit managers (PBMs) and prescription drug plans under Medicare. The goal is to provide more transparency on how these agreements impact out-of-pocket costs for Medicare enrollees and the reim

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill requires the Medicare Payment Advisory Commission to report on the agreements between pharmacy benefit managers (PBMs) and prescription drug plans under Medicare. The goal is to provide more transparency on how these agreements impact out-of-pocket costs for Medicare enrollees and the reimbursements received by pharmacies.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

PBM Reporting Transparency ActThis bill requires the Medicare Payment Advisory Commission to report certain information about pharmacy benefit managers (PBMs) under the Medicare prescription drug benefit and Medicare Advantage.Specifically, the commission must report on trends in agreements between PBMs and prescription drug plans, the impact of any differences in agreements on out-of-pocket spending for enrollees and pharmacy reimbursements, and any appropriate recommendations. The commission must submit an updated report two years after its initial report.

Key Points

Main provisions of the bill

The bill requires the Medicare Payment Advisory Commission to report on trends in agreements between PBMs and prescription drug plans.
The commission must analyze how any differences in these agreements affect out-of-pocket spending for Medicare enrollees and pharmacy reimbursements.
The commission must submit an updated report on this topic two years after the initial report.

How This Impacts Americans

Potential effects on citizens and communities

If this bill becomes law, it would impact Medicare enrollees and pharmacies by providing more transparency around the agreements between PBMs and prescription drug plans. This could lead to a better understanding of how these deals affect out-of-pocket costs for patients and reimbursements for pharmacies.

Policy Areas

Primary Policy Area

Health

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

2493, 119th Congress (2025). "Medical Disability Examination Improvement Act of 2025". Source: Voter's Right Platform. https://votersright.org/bills/118-s-2493